Benzeneacetamide, 4-butoxy-N-hydroxy-


Chemical Name: Benzeneacetamide, 4-butoxy-N-hydroxy-
CAS Number: 2438-72-4
Product Number: AG007NMA(AGN-PC-0JK69D)
Synonyms:
MDL No:
Molecular Formula: C12H17NO3
Molecular Weight: 223.2683

Identification/Properties


Computed Properties
Molecular Weight:
223.272g/mol
XLogP3:
1.9
Hydrogen Bond Donor Count:
2
Hydrogen Bond Acceptor Count:
3
Rotatable Bond Count:
6
Exact Mass:
223.121g/mol
Monoisotopic Mass:
223.121g/mol
Topological Polar Surface Area:
58.6A^2
Heavy Atom Count:
16
Formal Charge:
0
Complexity:
200
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


GHS Pictogram:
Signal Word:
Warning
UN#:
-
Hazard Statements:
H302
Precautionary Statements:
P280-P305+P351+P338
Class:
-
Packing Group:
-

NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



Bufexamac is commonly used in chemical synthesis as a versatile building block for the preparation of various pharmaceutical compounds. Its unique structure and properties make it a valuable intermediate in the synthesis of anti-inflammatory drugs, such as nonsteroidal anti-inflammatory agents (NSAIDs). Bufexamac can undergo various chemical reactions, including esterification, hydrolysis, and oxidation, to yield diverse derivatives with enhanced biological activity. Additionally, bufexamac's compatibility with a wide range of functional groups makes it a preferred choice for medicinal chemists seeking to develop new drug candidates. Its role in chemical synthesis extends beyond pharmaceuticals, as bufexamac is also utilized in the preparation of other bioactive molecules and materials. With its flexibility and effectiveness in generating structurally diverse compounds, bufexamac serves as a key component in advancing the field of chemical synthesis for therapeutic and research purposes.